Business Context and Reporting Period
Company: Contineum Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 13, 2026
Reporting Period: Single event date (July 13, 2026)
Business Context: The registrant is a Delaware corporation with its principal executive offices in San Diego, California. It is classified as an emerging growth company. The filing serves to disclose an update to the company's corporate presentation regarding business and strategic updates.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate presentation update and does not contain audited or unaudited financial statements.
Material Changes
Strategic Update: On July 13, 2026, the Company updated its corporate presentation to reflect certain business and strategic updates. The specific details of these changes are contained within the attached Exhibit 99.1 (Corporate Presentation) and are not detailed in the body of this 8-K filing.
Guidance, Outlook, and Risks
- Management Commentary: The Company intends to use its website (www.contineum-tx.com) to disseminate future updates to its corporate presentation and does not plan to file a Form 8-K for each subsequent update.
- Forward-Looking Statements: The information in the corporate presentation is summary information intended to be considered in the context of other SEC filings and public announcements.
- Legal Disclaimer: The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section. The Company undertakes no duty or obligation to publicly update or revise the information contained in this report.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Corporate Presentation) for specific details on the business and strategic updates mentioned in this filing.
- Verify the most recent financial position by consulting the Company's latest 10-K or 10-Q filings, as this 8-K contains no financial data.
- Monitor the Company's website for future updates to the corporate presentation, as the Company has stated it will not file an 8-K for every update.
- Confirm the Company's status as an emerging growth company and any associated election regarding extended transition periods for accounting standards.